Emerging Growth Equities, Ltd. Initiates Coverage of eResearchTechnology, Inc. (Nasdaq: ERES) with a BUY Rating
July 20 2004 - 3:44PM
PR Newswire (US)
Emerging Growth Equities, Ltd. Initiates Coverage of
eResearchTechnology, Inc. (Nasdaq: ERES) with a BUY Rating KING OF
PRUSSIA, Pa., July 20 /PRNewswire/ -- Emerging Growth Equities,
Ltd. initiates coverage of eResearchTechnology, Inc. (NASDAQ:ERES)
with a BUY rating and a 12-month price target of $37.50. eResearch
is the leader in ECG (electrocardiograph) analysis in support of
clinical trials evaluating the safety of pharmaceutical and
biologic product candidates. Emerging Growth Equities, Ltd. is a
specialty brokerage and investment banking firm providing
high-quality distribution, research and trade execution for
institutional and retail clients. Emerging Growth Equities, Ltd.
specializes in fulfilling the capital requirements of well-managed
emerging growth companies. Emerging Growth Equities, Ltd. maintains
a market in ERES with the market maker ID EGRO. For a full text of
the report please call 888-293-1800. This publication is neither an
offer to sell nor a solicitation to buy any securities mentioned
herein. The information contained herein is based on data obtained
from recognized sources that are believed to be reliable. Emerging
Growth Equities, Ltd. has not independently verified the facts,
assumptions and estimates contained in this report. Accordingly, no
representation or warranty, expressed or implied, is made as to,
and no reliance should be placed on, the fairness, accuracy,
completeness or correctness of the information and opinions
contained in this report. The information contained in this report
is not and does not purport to be a complete analysis of every
material fact respecting any company, industry, or security. Most
of the companies Emerging Growth Equities, Ltd. follows are
emerging and mid-sized growth companies whose securities typically
involve a higher degree of risk and more volatility than the
securities of more established companies. For these and other
reasons, the investments discussed or recommended in this report
may be unsuitable for investors depending on their specific
investment objectives and financial position. Transactions in
securities mentioned herein may be effected only in those states
where such securities are qualified for sale. Any statements
nonfactual in nature herein constitute only current opinions or
estimates, represent only the current judgment of the author(s),
and are subject to change without notice. This report contains
forward- looking statements, which involve risks and uncertainties.
Actual results may differ significantly from the results described
in the forward-looking statements. Emerging Growth Equities, Ltd.
(or one of its affiliates) or their partners, officers, directors,
analysts, employees or customers may have an interest in the
securities mentioned herein and may make purchases or sales as
principal or agent of these securities, or their derivatives, while
this report is in circulation. A partner, employee, analyst,
officer, or director of Emerging Growth Equities, Ltd. (or one of
its affiliates) may serve as a director or consultant for any
company mentioned herein. Emerging Growth Equities, Ltd. (or one of
its affiliates) may from time to time perform investment banking
services for, or solicit investment banking business or other
business from, any company mentioned herein. Additional information
on the securities discussed herein is available on request.
Emerging Growth Equities, Ltd. is a member of the National
Association of Securities Dealers, CRD number 47040. DATASOURCE:
Emerging Growth Equities, Ltd. CONTACT: Raymond A. Myers, CFA,
Healthcare Analyst, Emerging Growth Equities, Ltd., +1-610-783-4783
or +1-888-293-1800
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024